Outcome Measures: |
Primary: Percent Change in Total Cholesterol, Percent change in total cholesterol (mg/dl) from Baseline to Month 6., Baseline, Month 6|Percent Change in LDL-Cholesterol, Percent change in low-density lipoprotein (LDL) cholesterol (mg/dl) from baseline to Month 6, Baseline, Month 6|Percent Change in HDL Cholesterol, Percent change in high-density lipoprotein (HDL) cholesterol (mg/dl) from baseline to Month 6., Baseline, Month 6|Percent Change in Triglycerides, Percent change in triglycerides (mg/dl) from baseline to Month 6., Baseline, Month 6|Percent Change in TNF-alpha, Percent change in tumor necrosis factor (TNF)-alpha (pg/ml) from Baseline to Month 6., Baseline, Month 6|Percent Change in IL-6, Percent change in interleukin 6 (IL-6) (pg/ml) from baseline to Month 6, Baseline, Month 6|Percent Change in IL-8, Percent change in interleukin 8 (IL-8) (pg/ml) from baseline to Month 6., Baseline, Month 6|Percent Change in Ferritin, Percent change in ferritin (ng/ml) from baseline to Month 6., Baseline, Month 6|Percent Change in C-reactive Protein, Percent change in C-reactive Protein (mg/L) from baseline to Month 6., Baseline, Month 6|Percent Change in Homocysteine, Percent change in homocysteine (micromol/L) from baseline to Month 6., Baseline, Month 6|Change in Intravenous Iron Use, Change in intravenous iron use (mg) from Baseline to Month 6., Baseline, Month 6 | Secondary: Percent Change in Calcium, Percent change in calcium (mg/dL) from baseline to Month 6., Baseline, Month 6|Percent Change in Phosphorus, Percent change in phosphorus (md/dl) from baseline to Month 6., Baseline, Month 6|Percent Change in Parathyroid Hormone (PTH), Percent change in PTH (pg/ml) from baseline to Month 6., Baseline, Month 6
|